Buscar resultados de ensayos clínicos
Perlman Syndrome - 24 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor Condición: Wilms Tumor Fecha: 2005-09-12 Intervenciones: Drug: Topotecan, Filgrastim (G-CSF), Pegfilgrastim See detailed description section for additional detai |
Recruiting |
Nombre del estudio: Collaborative Wilms Tumour Africa Project Condición: Wilms Tumour Fecha: 2013-11-12 |
Withdrawn |
Nombre del estudio: National Wilm's Tumor Study Late Effects Condición: Wilm's Tumor Fecha: 2005-09-27 Intervenciones: Other: none, screening only Screening protocol with no intervention |
Active, not recruiting |
Nombre del estudio: Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor Condición:
|
Completed |
Nombre del estudio: Biomarkers in Samples From Younger Patients With Wilms Tumor Condición: Wilms Tumor and Other Childhood Kidney Tumors Fecha: 2011-12-15 Intervenciones: Other: laboratory biomarker analysis Correlative studies |
Completed |
Nombre del estudio: Studying Biomarkers in Urine Samples From Younger Patients With Wilms Tumor Condición:
|
Recruiting |
Nombre del estudio: Genetics of Wilms' Tumor and/or the Associated Conditions of Aniridia, Hemihypertrophy, and Genitourinary Anomalies Condición:
Fecha: 2007-07-17 Intervenciones:
|
Completed |
Nombre del estudio: A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor Condición:
Fecha: 1999-11-03 Intervenciones: Drug: IFN-alpha with retinoic acid |
Completed |
Nombre del estudio: Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor Condición:
|
Completed |
Nombre del estudio: WT1 Peptid Vaccination in Carcinomas Condición: WT1 Expressing Carcinoma Fecha: 2005-09-08 Intervenciones: Biological: WT1 126-134 peptide |